Lesotho vs Tanzania: Cause of death, by non-communicable diseases, female
Lesotho
40.6%
in 2021
Tanzania
41.6%
in 2021
Lesotho rank
160th
Tanzania rank
157th
Cause of death, by non-communicable diseases, female over time
- Lesotho
- Tanzania
How they compare
Tanzania currently reports 41.6% against 40.6% in Lesotho, a difference of 1.0%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Lesotho ahead.
Lesotho ranks 160th and Tanzania ranks 157th of 185 countries.
Lesotho has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lesotho | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.8% | 16.2% | 8.6% | Lesotho |
| 2010s | 40.8% | 32.8% | 8.0% | Lesotho |
| 2020s | 42.4% | 40.8% | 1.7% | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Lesotho or Tanzania?
- Tanzania, at 41.6% against 40.6% in Lesotho as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Lesotho and Tanzania?
- 1.0%, with Tanzania ahead.
- How many years of comparable data are there for Lesotho and Tanzania?
- 6 years are reported by both, from 2000 to 2021.
- How do Lesotho and Tanzania rank globally for cause of death, by non-communicable diseases, female?
- Lesotho ranks 160th and Tanzania ranks 157th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.